House to Vote on Pelosi Drug Pricing Bill This Week
On Dec. 5, it was announced that Speaker Nancy Pelosi’s (D-CA) drug pricing bill, H.R. 3, will be voted on next week in the full House. As of now, there is no complete score of projected savings from the Congressional Budget Office (CBO) before
Hearings/MarkupsHouse Committee on the Judiciary: “The Patent Trial and Appeal Board and the Appointments Clause: Implications of Recent Court Decisions”
Tuesday, Nov. 19, 2019: The House Committee on the Judiciary held a hearing on the patent system and implications of recent court decisions on the system.
Why this is important: On Nov. 20, the
Hearings/MarkupsSenate Health, Education, Labor and Pensions (HELP) Committee: “Examining the Response to Lung Illnesses and Rising Youth Electronic Cigarette Use”
Wednesday, Nov. 13, 2019: The Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing to examine the Food and Drug Administration’s (FDA) and Centers for Disease Control and Prevention’s (CDC) response to
Hearings/MarkupsSenate Special Committee on Aging: “Veteran Scams: Protecting Those Who Protected Us”
Wednesday, Nov. 6, 2019: The Senate Special Committee on Aging held a hearing on protecting veterans from a variety of scams, including fake charities. As a result of the witness testimonies, a letter was sent to Secretary of the Department of Veterans
Hearings/MarkupsSenate Committee on Finance: “Medicaid: Compliance with Eligibility Requirements”
Wednesday, Oct. 30, 2019: The Senate Committee on Finance, Subcommittee on Health held a hearing on eligibility requirements under the Medicaid program. This hearing foreshadows action that is expected to be taken by the administration soon related to states’ ensuring Medicaid recipients are eligible for
HearingsHouse Energy and Commerce Committee: “Sabotage: The Trump Administration’s Attack on Health Care”
Wednesday, Oct. 23, 2019: The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held to seek clarity on the Trump administration’s health care policy choices. The Centers for Medicare and Medicaid (CMS) Administrator Seema Verma testified at
Hearings/MarkupsHouse Ways and Means Committee: “Investing in the U.S. Health System by Lowering Drug Prices, Reducing Out-of-Pocket Costs, and Improving Medicare Benefits”
The House Ways and Means Committee held a hearing on prescription drug pricing costs, as well as discussing the government drug price negotiation plan released by House Speaker Nancy Pelosi (D-CA), H.R.
HouseBlue Dog Democrats Urge Speaker Pelosi to Call Vote on Several Bipartisan Drug-pricing Bills
On Oct. 7, the Blue Dog Coalition asked House Speaker Nancy Pelosi to hold votes on several bipartisan drug-pricing bills, instead of wrapping them into government price negotiation legislation, the same request Republicans are making to the speaker. The Blue
HouseBipartisan Legislation Introduced on Accurate Provider Directories
On Sept. 27, Reps. Phil Roe (R-TN) and Kim Schrier (D-WA) introduced legislation to improve the accuracy of the information listed on health plans’ provider directories to prevent patients from receiving surprise out-of-network bills. The Improving Provider Directories Act (H.R. 4575) requires health plans to establish a
Hearings/MarkupsSenate Special Committee on Aging: “Promoting Healthy Aging – Living Your Best Life Long into Your Golden Years”
The Senate Special Committee on Aging held a hearing for seniors seeking to maintain a healthy lifestyle as they age. Find the hearing transcript here.
House Energy and Commerce Committee, Subcommittee on Health: “Making Prescription Drugs